Standard / personal best
Tesamorelin
GH Axis & Hormone Support
GHRH analog used for GH-axis signaling and waistline-focused recomposition.
Best lane is visceral-fat/waistline support, sleep and recovery rhythm, and body composition. Official products have specific labeling.
Dosage discussion lanes
- Starting / standard
- Common clinic discussion: 0.5–1 mg nightly; the official Egrifta SV label uses 1.4 mg daily for its indicated population.
- Personal best / low-activity
- 1 mg nightly is often used as a conservative personal-best discussion.
- Heavy trainer / athlete
- 1–2 mg nightly discussions are common in heavy training/recomp contexts with glucose and IGF-1 monitoring.
- Timing
- Bedtime on an empty stomach.
- Cycle
- 8–12 weeks on, then 4 weeks off or lab-guided reassessment.
- Men vs women
- Women and smaller users often start at 0.5–1 mg.
Watch-outs
Glucose/insulin resistance, edema, joint symptoms, IGF-1 elevation; not for active malignancy.
Dose framework only. Do not convert to syringe units until product concentration and reconstitution volume are known. Adjust only with qualified oversight and side-effect tracking.
In our catalog
Educational and comparative only. Not a prescription, medical advice, or instruction to self-administer. Start low, change one variable at a time, and match the compound to the goal. Product formulation, route, concentration, lab work, medical history, medications, and legal/regulatory status change the plan.